{"gene":"TSC22D1","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":1992,"finding":"TSC-22 (TSC22D1) was originally isolated as an immediate-early TGF-β1-inducible gene in mouse osteoblastic cells, encoding an ~18 kDa protein containing a leucine zipper motif and a TSC-box.","method":"Differential screening of osteoblast cDNA library; protein characterization","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — referenced across multiple independent papers as foundational finding, but original methods described only in secondary citations within corpus","pmids":["15881652"],"is_preprint":false},{"year":1998,"finding":"Down-regulation of TSC-22 in human salivary gland cancer cells markedly enhanced their in vitro and in vivo growth, while up-regulation did not affect growth, establishing TSC-22 as a negative growth regulator relevant to salivary gland tumorigenesis.","method":"Sense/antisense cDNA transfection, ELISA protein quantification, in vitro growth assay, nude mouse tumorigenicity assay","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined cellular and in vivo phenotype, replicated in follow-up studies from same group","pmids":["9458104"],"is_preprint":false},{"year":1998,"finding":"TSC-22 induction by vesnarinone required ongoing protein synthesis (blocked by cycloheximide), and antisense suppression of TSC-22 stimulated TYS cell growth and blocked vesnarinone's antiproliferative effect, confirming TSC-22 as a negative growth regulator.","method":"Antisense oligonucleotide treatment, cycloheximide block, cell growth assay","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — antisense loss-of-function with growth phenotype, consistent with independent study","pmids":["9459148"],"is_preprint":false},{"year":2000,"finding":"TSC-22-GFP fusion protein localizes to the cytoplasm in living cells, but translocates to the nucleus in apoptotic cells; overexpression of cytoplasmic TSC-22 enhanced sensitivity to anticancer drugs (5-FU, CDDP, peplomycin) and markedly enhanced 5-FU-induced apoptosis.","method":"GFP fusion protein live-cell imaging, drug sensitivity assays, apoptosis assays in transfected cells","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization by live imaging tied to functional apoptosis outcome, single lab","pmids":["10879745"],"is_preprint":false},{"year":2000,"finding":"TSC-22-GFP translocates from cytoplasm to nucleus specifically during apoptosis; TSC-22 fused to GAL4-DNA binding domain showed transcriptional activation in CHO cells but not HeLa or yeast, and the leucine zipper domain had greater transcriptional activity than full-length TSC-22.","method":"GFP fusion protein live/apoptotic cell imaging, GAL4-reporter assays in multiple cell lines and yeast","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional transcription reporter, multiple cell systems, single lab","pmids":["11095965"],"is_preprint":false},{"year":2002,"finding":"Cytoplasmic localization of TSC-22 (full-length, containing nuclear export signal) enhanced radiation sensitivity of salivary gland cancer cells, whereas the nuclear-only TSC-22 (NLS-TSC-22LZ) had marginal effect; cytoplasmic TSC-22 translocated to nucleus during radiation-induced apoptosis, demonstrating that cytoplasmic-to-nuclear translocation is important for the cell death signal.","method":"Transfection of TSC-22 constructs with/without NLS/NES, radiation sensitivity assays, subcellular localization imaging","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-deletion constructs with localization and functional phenotype, single lab","pmids":["11944908"],"is_preprint":false},{"year":2002,"finding":"The leucine zipper domain of TSC-22 is the active domain for inhibiting anchorage-independent colony formation; full-length TSC-22 (cytoplasmic) had weaker effect, and nuclear leucine zipper construct was most potent.","method":"Transfection of domain-deletion constructs, anchorage-independent growth (soft agar) assay","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mutagenesis with functional phenotype, single lab","pmids":["11836610"],"is_preprint":false},{"year":2002,"finding":"TSC-22 is a downstream effector of both PPARγ and TGF-β signaling in intestinal epithelial cells; transfection of wild-type TSC-22 reduced growth and increased p21, and a dominant-negative TSC-22 (both repressor domains deleted) reversed p21 induction and growth inhibition by PPARγ or TGF-β activation.","method":"PPARγ ligand treatment, TGF-β treatment, wild-type and dominant-negative TSC-22 transfection, p21 immunoblot, growth assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative epistasis places TSC-22 downstream of two pathways with defined phenotype, single lab","pmids":["12468551"],"is_preprint":false},{"year":2003,"finding":"TGF-β1 upregulates TSC-22 mRNA through mRNA stabilization rather than transcriptional activation: the TSC-22 promoter was not activated by TGF-β signaling, but the 3'-UTR (containing Shaw-Kamens AUUUA sequences) destabilized heterologous mRNA, and TGF-β1 relieved this destabilization; a 40 kDa protein bound the 3'-UTR and this complex was decreased by TGF-β1.","method":"Promoter-luciferase assay, RNA-protein binding assay, heterologous mRNA stability reporter assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (luciferase, RNA-binding, stability assay), single lab","pmids":["12767908"],"is_preprint":false},{"year":2005,"finding":"Tsc-22 binds directly to Smad3 and Smad4 and modulates their transcriptional activity, enhancing TGF-β-dependent signaling; Tsc-22 also induced erythroid cell differentiation.","method":"Co-immunoprecipitation, transcriptional reporter assays, differentiation assays","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP binding to Smads with functional reporter, replicated in part by later studies","pmids":["15881652"],"is_preprint":false},{"year":2007,"finding":"TSC-22 is a transcriptional suppressor of Gadd45b in mouse liver cells: siRNA knockdown of Tsc-22 increased Gadd45b gene and protein expression over time, and oxazepam treatment also decreased Tsc-22 and increased Gadd45b, placing Tsc-22 upstream of Gadd45b in an antiapoptotic pathway.","method":"siRNA knockdown, RT-PCR, western blot, oxazepam chemical treatment","journal":"Toxicological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined downstream target, two orthogonal perturbations (siRNA and chemical), single lab","pmids":["17533171"],"is_preprint":false},{"year":2008,"finding":"TSC-22 interacts with fortilin (a nuclear anti-apoptotic protein), and fortilin overexpression reverses TSC-22-mediated apoptosis by promoting TSC-22 protein degradation; fortilin siRNA knockdown increased apoptosis.","method":"Yeast two-hybrid screening, Co-IP, overexpression/siRNA in ovarian carcinoma cells, apoptosis assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid + Co-IP binding, functional rescue experiment, single lab","pmids":["18325344"],"is_preprint":false},{"year":2008,"finding":"The Drosophila TSC-22 homolog Bunched (Bun) large isoforms promote cellular growth and proliferation; loss of large isoforms increases apoptosis and reduces cell size and division frequency in S2 cells and follicle cells, demonstrating a growth-promoting (not suppressive) function for the long isoform.","method":"Drosophila genetics (loss-of-function clonal analysis), S2 cell RNAi depletion, cell size and division measurements","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotypes in multiple contexts, single lab","pmids":["18375761"],"is_preprint":false},{"year":2008,"finding":"The Drosophila bunched large isoform BunA promotes growth (cell number and cell size), while short isoforms BunB and BunC antagonize BunA function, establishing opposing roles for long vs. short isoforms at the single TSC-22/bun locus.","method":"Unbiased genetic screen, bun loss-of-function mutants, isoform-specific overexpression, cell size and number quantification","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic screen and isoform-specific rescue experiments, independent lab from PMID:18375761 but consistent results","pmids":["18226226"],"is_preprint":false},{"year":2008,"finding":"A 16-residue sequence within the conserved 56-residue TSC22 domain (not the leucine zipper) is necessary for TSC-22's anti-apoptotic activity in yeast Bax-suppression assays; deletion mutagenesis and two-hybrid screening showed the antiapoptotic effect is independent of leucine zipper-mediated transcription.","method":"Yeast Bax-suppression assay, deletion mutagenesis, genome-wide two-hybrid screen, yeast overexpression/knockout","journal":"FEMS yeast research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional readout and deletion mapping, single lab","pmids":["18355271"],"is_preprint":false},{"year":2009,"finding":"TSC-22D1 isoform 2 (short isoform) induces cell death in mammary epithelial cells and is upregulated during mammary gland involution, while isoform 1 (long isoform) suppresses TGF-β-induced cell death and enhances proliferation; the two isoforms exert opposing effects on cell survival.","method":"Isoform-specific overexpression/depletion in mammary epithelial cell lines, mammary gland in vivo expression analysis, cell death assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific gain/loss-of-function with defined cell survival phenotypes, single lab","pmids":["19745830"],"is_preprint":false},{"year":2009,"finding":"TSC-22 promoter is hypermethylated in T/NK LGL leukemia, silencing its expression; targeted disruption of TSC-22 in mice enhanced proliferation and in vivo repopulation of hematopoietic precursor cells (HPCs), demonstrating a role for TSC-22 in restraining HPC expansion.","method":"Methylation analysis, 5-aza-2'-deoxycytidine treatment in vivo, TSC-22 knockout mouse model, HPC repopulation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse with defined HPC phenotype plus epigenetic mechanism, replicated across multiple disease models","pmids":["19329776"],"is_preprint":false},{"year":2010,"finding":"TGF-β increases Tsc-22 protein levels post-transcriptionally in mesangial cells via miR-216a-mediated down-regulation of Ybx1; Ybx1 forms a ribonucleoprotein complex with Tsc-22 mRNA that stabilizes it, and TGF-β disrupts this complex to increase Tsc-22 protein. Tsc-22 then interacts with Tfe3 and both occupy E-box enhancers of Col1a2 to drive collagen expression.","method":"miRNA mimic/inhibitor oligonucleotides, Ybx1 shRNA knockdown, RNP complex co-immunoprecipitation, ChIP assay for Tsc-22 and Tfe3 on Col1a2 E-boxes, co-IP for Tsc-22/Tfe3 interaction","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (RNP-IP, ChIP, co-IP, miRNA perturbation) in single study establishing post-transcriptional regulation and chromatin occupancy","pmids":["20713358"],"is_preprint":false},{"year":2010,"finding":"TSC22D1 is required for TGF-β1- and PDGF-BB-stimulated CNP (C-type natriuretic peptide) expression in human vascular smooth muscle cells; siRNA suppression of TSC22D1 (~90% knockdown) reduced TGF-β- and PDGF-stimulated CNP expression by 45–65%, establishing TSC22D1 as an enhancer of CNP transcription downstream of TGF-β.","method":"siRNA knockdown of TSC22D1, qRT-PCR for CNP and TSC22D1 mRNA, TGF-β1/PDGF-BB treatment in primary human vascular SMCs","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA loss-of-function with defined transcriptional target, two growth factor stimuli, single lab","pmids":["20802130"],"is_preprint":false},{"year":2011,"finding":"TSC-22 facilitates TGF-β signaling by interacting with TβRI and Smad7 in mutually exclusive ways, disrupting the Smad7/Smurf-TβRI association and thereby preventing TβRI ubiquitination and degradation. This leads to enhanced Smad2/3 phosphorylation and promotes cardiac myofibroblast differentiation. The stimulatory effect of TSC-22 is abolished when Smad7 is silenced.","method":"Co-IP of TSC-22 with TβRI and Smad7, ubiquitination assays, Smad2/3 phosphorylation immunoblot, Smad7 siRNA epistasis, myofibroblast differentiation markers (α-SMA, PAI-1, fibronectin, collagen I), isoproterenol rat model","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ubiquitination assay, siRNA epistasis, and in vivo corroboration; multiple orthogonal methods in one study","pmids":["21791611"],"is_preprint":false},{"year":2011,"finding":"BRAF(E600)-induced senescence upregulates only the short TSC22D1 transcript (>100-fold); the long TSC22D1 protein variant is degraded by proteasomal degradation. Short and long TSC22D1 variants form complexes with their dimerization partner THG1 and exert opposing functions: depletion of the short form or overexpression of the long form abrogates oncogene-induced senescence (OIS). TSC22D1 acts as a critical effector of C/EBPβ in OIS, controlling inflammatory factors and p15(INK4B).","method":"Gene expression profiling, isoform-specific depletion (short form), long isoform overexpression, proteasome inhibition, senescence assays, C/EBPβ epistasis analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific gain/loss-of-function with mechanistic pathway placement (C/EBPβ), multiple orthogonal methods, defined OIS phenotype","pmids":["21448135"],"is_preprint":false},{"year":2011,"finding":"PKC regulation of TGF-β signaling depends on Tsc-22 inducibility: in cells where Tsc-22 is induced, Tsc-22 enhances TGF-β-dependent signaling, and a dominant-negative Tsc-22 mutant blocks this enhancement, demonstrating cell-type-specific modulation of the Smad-PKC axis by Tsc-22.","method":"Dominant-negative TSC-22 mutant transfection, TGF-β signaling reporter assays, comparison across cell types","journal":"Molecular and cellular biochemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — dominant-negative experiment in single lab without detailed mechanistic dissection","pmids":["21881999"],"is_preprint":false},{"year":2012,"finding":"TSC-22 binds directly to p53 at the motif between amino acids 100–200, inhibiting HDM2- and E6-mediated poly-ubiquitination and degradation of p53, thereby stabilizing p53 and activating p21(Waf1/Cip1) and PUMA expression. TSC-22 siRNA knockdown enhanced p53 poly-ubiquitination. Notably, TSC-22 did not affect the p53–HDM2 interaction itself.","method":"Co-IP of TSC-22 and p53, ubiquitination assays, siRNA knockdown, overexpression in cervical cancer cells and xenograft model, p21/PUMA western blot","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination assay, and siRNA with defined downstream targets, single lab","pmids":["22870275"],"is_preprint":false},{"year":2016,"finding":"TSC-22 promotes apoptosis in IL-2-deprived T-lymphocytes by inhibiting GILZ expression at the transcriptional level, resulting in increased BIM expression and elevated caspase-9 and caspase-3 activities.","method":"TSC-22 overexpression in CTLL-2 and NKL cell lines, IL-2 withdrawal apoptosis assay, GILZ mRNA quantification, BIM/caspase activity measurements","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with defined transcriptional target and apoptosis pathway, single lab","pmids":["26752201"],"is_preprint":false},{"year":2017,"finding":"TSC-22 interacts with the intracellular tyrosine kinase insert domain (aa 539–749) of CSF-1R, blocking AKT and ERK signaling and suppressing NF-κB transcriptional activity; TSC-22 overexpression also decreased CSF-1R protein levels, disrupting its autocrine signaling loop.","method":"Co-IP of TSC-22 and CSF-1R, domain mapping, AKT/ERK/NF-κB signaling assays, CSF-1R protein level quantification, xenograft tumor model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping plus downstream signaling readouts, single lab","pmids":["29228668"],"is_preprint":false},{"year":2019,"finding":"TSC22D4-TSC22D1 short isoform heterodimers promote cell cycle exit and escape from proliferation in medulloblastoma cells, whereas the TSC22D1 long isoform supports cell proliferation independently of TSC22D4; silencing specific isoforms affects cell-cycle progression.","method":"siRNA isoform-specific knockdown of TSC22D1 long/short and TSC22D4, cell cycle analysis in DAOY medulloblastoma cells","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific RNAi with cell cycle phenotype, single lab","pmids":["30912127"],"is_preprint":false},{"year":2021,"finding":"TSC22D1-1 (long isoform) localizes predominantly to the nucleus; TSC-22 (TSC22D1-2, short isoform) localizes to the cytoplasm (mainly mitochondria) and translocates to nucleus after DNA damage; TSC22(86) (TSC22D1-3) localizes to both compartments. Pull-down and in vivo binding assays identified Histone H1 as a binding partner of TSC22D1-2 and TSC22D1-3 in the nucleus, and GNL3/nucleostemin as a binding partner of TSC22D1-2 in the nucleus.","method":"GFP-fusion localization imaging, subcellular fractionation, in vitro pull-down assays, in vivo binding assays, mass spectrometry","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiments plus pull-down/MS identification of binding partners, single lab","pmids":["34681573"],"is_preprint":false},{"year":2022,"finding":"MEX3D RNA-binding protein directly binds TSC22D1 mRNA and destabilizes it, reducing TSC22D1 expression in cervical cancer; MEX3D knockdown increased TSC22D1 levels, and this was confirmed by RNA pull-down, RNA immunoprecipitation, and mRNA stability assays.","method":"RNA pull-down, RNA immunoprecipitation (RIP), mRNA stability assays, MEX3D knockdown, western blot","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal RNA-binding assays establishing direct RBP-mRNA interaction with functional mRNA stability consequence, single lab","pmids":["35513372"],"is_preprint":false},{"year":2022,"finding":"TSC-22 directly interacts with BRD7 and potentiates BRD7-mediated inactivation of the ERK signaling pathway in ovarian cancer cells.","method":"Co-IP identification of TSC-22/BRD7 interaction, ERK pathway activity assays with TSC-22 overexpression","journal":"Development & Reproduction","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP with downstream signaling readout, single lab, limited detail in abstract","pmids":["36285148"],"is_preprint":false},{"year":2024,"finding":"TSC22D1 long isoform (TSC22D1.1) localizes to WNK bodies (cytoplasmic biomolecular condensates) in the distal convoluted tubule of the kidney and positively modulates WNK4 signaling; long TSC22D isoforms and NRBP1 increase WNK4 activity in HEK293 cells, and this is associated with regulation of NCC phosphorylation and Na+ reabsorption.","method":"Subcellular localization in kidney DCT cells, HEK293 WNK4 activity assay, DCT-specific NRBP1 knockout mouse model, NCC phosphorylation immunoblot","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — localization in native tissue context, in vitro kinase pathway assay, and KO mouse with defined physiological phenotype; preprint not yet peer-reviewed","pmids":["bio_10.1101_2024.12.12.628222"],"is_preprint":true},{"year":2024,"finding":"TSC22D1 contains an RΦ-motif that interacts with the CCT-like domain of the pseudokinase NRBP1, and AlphaFold-3 modeling predicts TSC22D1 forms part of a multi-subunit complex with WNK1, SPAK, and TSC22D4 via RΦ-motif interactions with CCT domains.","method":"Motif interaction analysis, immunoprecipitation, mass spectrometry, AlphaFold-3 structural modeling","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 4 / Weak — structural model is computational; experimental validation of TSC22D1 motif binding to NRBP1 CCT domain shown by peptide binding but full complex not reconstituted; preprint","pmids":["bio_10.1101_2024.06.26.600905"],"is_preprint":true},{"year":2025,"finding":"TSC22D1 interacts with FoxO1 in a reciprocal manner to regulate pancreatic beta cell function; TSC22D1 depletion in INS-1E cells enhanced expression of beta cell identity genes (Ins1, Ins2, Pdx1, Slc2a2, Nkx6.1) and promoted glucose-stimulated insulin secretion without altering intracellular insulin content.","method":"TSC22D1 siRNA depletion in INS-1E cells, glucose-stimulated insulin secretion assay, gene expression profiling (RNA-Seq), interactome analysis, Co-IP of TSC22D1 and FoxO1","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined transcriptional and secretory phenotype plus Co-IP interaction, single lab","pmids":["40679946"],"is_preprint":false},{"year":2025,"finding":"TSC22D1 drives liver sinusoidal endothelial cell (LSEC) dysfunction and M1 macrophage polarization via the TWEAK/FN14 signaling pathway; TSC22D1 overexpression in LSECs increased pro-inflammatory cytokine secretion and LSEC microvascularization/EndMT, and TWEAK inhibition attenuated these effects; AAV8-shRNA inhibition of TSC22D1 in vivo reduced NAFLD progression.","method":"Single-cell transcriptomic analysis, TSC22D1 overexpression in human LSECs, flow cytometry, ELISA, TWEAK inhibitor treatment, AAV8-shRNA in vivo knockdown in NAFLD mice","journal":"World journal of gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo loss/gain-of-function with defined pathway (TWEAK/FN14) and cellular phenotypes, single lab","pmids":["40901684"],"is_preprint":false}],"current_model":"TSC22D1 encodes a leucine zipper/TSC-box protein whose two major isoforms (long and short) exert opposing functions: the short isoform (TSC-22/TSC22D1-2) localizes to the cytoplasm (primarily mitochondria), translocates to the nucleus upon apoptotic or DNA damage stimuli, promotes cell cycle exit, p53 stabilization (by blocking poly-ubiquitination), and apoptosis, while suppressing oncogene-induced senescence when absent; the long isoform (TSC22D1-1) promotes cell proliferation and growth and is required for full TGF-β signaling amplification by displacing the Smad7/Smurf inhibitory complex from TβRI to prevent receptor degradation. Both isoforms act downstream of TGF-β (with mRNA upregulation achieved post-transcriptionally via mRNA stabilization rather than transcriptional activation), interact with Smad3/4, Tfe3, p53, fortilin, CSF-1R, FoxO1, WNK kinases (via RΦ-motif/CCT interactions), and BRD7, and their relative balance controls cell proliferation, differentiation, senescence, and organ-specific physiology including renal Na⁺ reabsorption and pancreatic beta cell function."},"narrative":{"mechanistic_narrative":"TSC22D1 encodes a leucine-zipper/TSC-box protein originally isolated as an immediate-early TGF-β1-inducible gene [PMID:15881652] that functions as a context-dependent regulator of cell proliferation, survival, and differentiation downstream of TGF-β signaling. Its expression is controlled largely post-transcriptionally: TGF-β1 stabilizes TSC22D1 mRNA by relieving 3'-UTR-mediated destabilization [PMID:12767908], and TGF-β acting through miR-216a-dependent loss of the stabilizing protein Ybx1 raises Tsc-22 protein levels [PMID:20713358], while the RNA-binding protein MEX3D directly binds and destabilizes TSC22D1 mRNA [PMID:35513372]. The locus produces functionally opposing isoforms: a short cytoplasmic isoform that translocates to the nucleus upon apoptotic or DNA-damage stimuli to drive cell death, and a long isoform that supports proliferation and growth [PMID:19745830, PMID:21448135, PMID:34681573], a division mirrored in the Drosophila bunched locus where long isoforms promote growth and short isoforms antagonize them [PMID:18226226]. Mechanistically, TSC22D1 amplifies TGF-β signaling by binding Smad3/Smad4 [PMID:15881652] and by competing with the Smad7/Smurf inhibitory complex at the type I receptor TβRI to block its ubiquitination and degradation, thereby sustaining Smad2/3 phosphorylation and myofibroblast differentiation [PMID:21791611]; it also partners with Tfe3 at Col1a2 E-box enhancers to drive collagen expression [PMID:20713358]. Its short isoform promotes apoptosis and cell-cycle exit by stabilizing p53 through inhibition of HDM2/E6-mediated poly-ubiquitination, activating p21 and PUMA [PMID:22870275], by repressing the anti-apoptotic targets Gadd45b [PMID:17533171] and GILZ [PMID:26752201], and acts as an effector of C/EBPβ in oncogene-induced senescence [PMID:21448135]. Loss-of-function studies establish it as a negative growth regulator in salivary gland cancer [PMID:9458104, PMID:9459148] and a restraint on hematopoietic precursor expansion [PMID:19329776]. Additional roles include modulation of WNK4 kinase signaling and renal Na⁺ handling via the long isoform localizing to WNK bodies [PMID:bio_10.1101_2024.12.12.628222] and reciprocal regulation of FoxO1 in pancreatic beta-cell function [PMID:40679946].","teleology":[{"year":1992,"claim":"Established the molecular identity of TSC22D1 as a TGF-β-responsive leucine-zipper/TSC-box protein, defining the structural elements later dissected for function.","evidence":"Differential cDNA screening of TGF-β1-induced osteoblasts and protein characterization","pmids":["15881652"],"confidence":"Medium","gaps":["Original isolation described only in secondary citations within the corpus","No structural model of the TSC-box or leucine zipper"]},{"year":1998,"claim":"Demonstrated that TSC22D1 acts as a tumor-suppressive negative growth regulator, answering whether its TGF-β inducibility translated into a growth-restraining cellular role.","evidence":"Sense/antisense transfection, nude-mouse tumorigenicity, antisense oligonucleotide and cycloheximide block in salivary gland cancer cells","pmids":["9458104","9459148"],"confidence":"Medium","gaps":["Molecular mechanism of growth suppression not resolved","Isoform contributions not distinguished"]},{"year":2002,"claim":"Linked TSC22D1 subcellular trafficking to apoptotic signaling and mapped the active domains, showing cytoplasmic-to-nuclear translocation drives the cell-death response and the leucine zipper mediates growth suppression.","evidence":"GFP-fusion live-cell imaging, NLS/NES constructs, GAL4-reporter and soft-agar assays in cancer cells","pmids":["10879745","11095965","11944908","11836610"],"confidence":"Medium","gaps":["Translocation trigger and transport machinery unidentified","Direct transcriptional targets of the leucine zipper not defined"]},{"year":2003,"claim":"Resolved how TGF-β raises TSC22D1 levels, showing regulation is post-transcriptional via 3'-UTR mRNA stabilization rather than promoter activation.","evidence":"Promoter-luciferase, RNA-protein binding, and heterologous mRNA stability reporter assays","pmids":["12767908"],"confidence":"Medium","gaps":["Identity of the 40 kDa 3'-UTR-binding protein not established","Did not connect stabilization to downstream phenotype"]},{"year":2007,"claim":"Placed TSC22D1 upstream of specific apoptotic effectors as a transcriptional suppressor of Gadd45b, extending its role beyond TGF-β amplification.","evidence":"siRNA knockdown and oxazepam treatment with RT-PCR/western in mouse liver cells","pmids":["17533171"],"confidence":"Medium","gaps":["Direct vs. indirect repression of Gadd45b not distinguished","No promoter occupancy data"]},{"year":2008,"claim":"Defined the opposing-isoform paradigm and a leucine-zipper-independent anti-apoptotic activity, reframing TSC22D1 as a locus encoding antagonistic long and short products.","evidence":"Drosophila bunched genetics, isoform-specific overexpression, yeast Bax-suppression assay and deletion mapping; fortilin yeast two-hybrid and Co-IP","pmids":["18375761","18226226","18355271","18325344"],"confidence":"Medium","gaps":["Mammalian validation of fly isoform model incomplete at this stage","Mechanism by which the TSC22-domain peptide suppresses apoptosis unknown"]},{"year":2009,"claim":"Confirmed in mammalian cells that the short isoform induces death while the long isoform suppresses TGF-β-induced death, and linked TSC22D1 to restraint of hematopoietic precursor expansion via epigenetic silencing.","evidence":"Isoform-specific gain/loss in mammary epithelium and in vivo involution analysis; promoter methylation analysis and TSC-22 knockout mouse HPC repopulation assay","pmids":["19745830","19329776"],"confidence":"High","gaps":["Molecular basis of opposing isoform outputs not fully defined","Tissue-specific isoform ratios uncharacterized"]},{"year":2010,"claim":"Identified a complete post-transcriptional control circuit (miR-216a/Ybx1) and a chromatin-level effector function with Tfe3, linking TGF-β input to collagen gene output.","evidence":"miRNA mimic/inhibitor, Ybx1 shRNA, RNP-IP, co-IP and ChIP on Col1a2 E-boxes in mesangial cells; siRNA in vascular SMCs for CNP","pmids":["20713358","20802130"],"confidence":"High","gaps":["Whether Tfe3 partnership generalizes beyond Col1a2 unknown","Isoform identity at chromatin not specified"]},{"year":2011,"claim":"Established the core mechanism of TGF-β amplification—TSC22D1 displaces Smad7/Smurf from TβRI to block receptor degradation—and defined its role as a C/EBPβ effector in oncogene-induced senescence.","evidence":"Reciprocal Co-IP, ubiquitination assays, Smad7 siRNA epistasis and isoproterenol rat model; isoform-specific depletion/overexpression, proteasome inhibition and C/EBPβ epistasis in OIS","pmids":["21791611","21448135","21881999"],"confidence":"High","gaps":["Stoichiometry of TβRI/Smad7 competition not resolved","How short-isoform induction is selectively triggered in senescence unclear"]},{"year":2012,"claim":"Identified a direct p53-stabilizing mechanism, explaining how the short isoform engages the apoptotic/cell-cycle-arrest program independently of transcription.","evidence":"Co-IP, ubiquitination assays, siRNA and overexpression with xenograft in cervical cancer cells","pmids":["22870275"],"confidence":"Medium","gaps":["How TSC-22 blocks ubiquitination without affecting p53–HDM2 binding is unexplained","Structural basis of the aa100–200 interaction unknown"]},{"year":2016,"claim":"Extended the pro-apoptotic mechanism to immune cells, showing transcriptional repression of GILZ drives BIM-dependent caspase activation upon IL-2 deprivation.","evidence":"Overexpression in CTLL-2/NKL cells with IL-2 withdrawal, GILZ/BIM and caspase readouts","pmids":["26752201"],"confidence":"Medium","gaps":["Direct vs. indirect GILZ repression not established","Isoform responsible not specified"]},{"year":2017,"claim":"Broadened the interactome to receptor tyrosine kinase signaling, showing TSC22D1 binds the CSF-1R kinase insert and suppresses AKT/ERK/NF-κB output.","evidence":"Co-IP, domain mapping, downstream signaling assays and xenograft","pmids":["29228668"],"confidence":"Medium","gaps":["Whether interaction directly inhibits kinase activity unknown","Isoform specificity not determined"]},{"year":2021,"claim":"Resolved isoform-specific subcellular distributions and identified new nuclear binding partners, refining the spatial logic of TSC22D1 isoform function.","evidence":"GFP localization, subcellular fractionation, pull-down and MS in transfected cells","pmids":["34681573"],"confidence":"Medium","gaps":["Functional consequences of Histone H1 and GNL3 binding not tested","Mitochondrial role of the short isoform undefined"]},{"year":2022,"claim":"Added MEX3D as a direct destabilizing regulator of TSC22D1 mRNA and BRD7 as a cooperating ERK-pathway partner, expanding upstream and signaling control.","evidence":"RNA pull-down, RIP and stability assays with MEX3D knockdown; Co-IP and ERK assays for BRD7","pmids":["35513372","36285148"],"confidence":"Medium","gaps":["BRD7 interaction supported by a single Co-IP with limited detail","Interplay between MEX3D and TGF-β-driven stabilization untested"]},{"year":2025,"claim":"Defined organ-specific physiological roles, implicating TSC22D1 in renal WNK signaling, pancreatic beta-cell identity/insulin secretion via FoxO1, and NAFLD-associated endothelial dysfunction via TWEAK/FN14.","evidence":"WNK body localization and HEK293 WNK4 activity assays with NRBP1 KO mouse (preprint); siRNA depletion, RNA-Seq and Co-IP in INS-1E cells; single-cell transcriptomics, overexpression and AAV8-shRNA in NAFLD mice","pmids":["bio_10.1101_2024.12.12.628222","40679946","40901684"],"confidence":"Medium","gaps":["Whether WNK-pathway role connects to the canonical TGF-β/apoptosis functions unknown","FoxO1 and TWEAK/FN14 mechanisms not integrated with isoform biology"]},{"year":null,"claim":"How TSC22D1 assembles into a higher-order complex with NRBP1/WNK/SPAK via RΦ-motif/CCT interactions, and how this structural context governs the choice between its proliferative and pro-apoptotic outputs, remains unresolved.","evidence":"AlphaFold-3 modeling with peptide-binding validation; full complex not reconstituted (preprint)","pmids":[],"confidence":"Low","gaps":["Predicted multi-subunit complex computationally modeled but not experimentally reconstituted","No structure of any TSC22D1 protein complex","Determinants selecting long vs. short isoform function unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[10,17,20,23]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[19,22,24]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[9,19]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[26]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,4,5,26]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,4,5,26]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[26]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3,22,23]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[20,25]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[20]}],"complexes":["WNK bodies"],"partners":["SMAD3","SMAD4","SMAD7","TGFBR1","TFE3","TP53","FOXO1","NRBP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15714","full_name":"TSC22 domain family protein 1","aliases":["Cerebral protein 2","HUCEP-2","Regulatory protein TSC-22","TGFB-stimulated clone 22 homolog","Transforming growth factor beta-1-induced transcript 4 protein"],"length_aa":1073,"mass_kda":109.7,"function":"Transcriptional repressor (PubMed:10488076). Acts on the C-type natriuretic peptide (CNP) promoter (PubMed:9022669). Acts to promote CASP3-mediated apoptosis (PubMed:18325344). Positively regulates TGF-beta signaling by interacting with SMAD7 which inhibits binding of SMAD7 to TGFBR1, preventing recruitment of SMURF ubiquitin ligases to TGFBR1 and inhibiting SMURF-mediated ubiquitination and degradation of TGFBR1 (PubMed:21791611). Contributes to enhancement of TGF-beta signaling by binding to and modulating the transcription activator activity of SMAD4 (PubMed:15881652). Promotes TGF-beta-induced transcription of COL1A2; via its interaction with TFE3 at E-boxes in the gene proximal promoter (By similarity). Plays a role in the repression of hematopoietic precursor cell growth (By similarity). Promotes IL2 deprivation-induced apoptosis in T-lymphocytes, via repression of TSC22D3/GILZ transcription and activation of the caspase cascade (PubMed:26752201) May act to negatively regulate TGFB3 signaling and thereby inhibit cell death in mammary gland cells Positively regulates cell death in response to TGFB3 during mammary gland involution","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q15714/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TSC22D1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NRBP1","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/TSC22D1","total_profiled":1310},"omim":[{"mim_id":"611914","title":"TSC22 DOMAIN FAMILY, MEMBER 4; TSC22D4","url":"https://www.omim.org/entry/611914"},{"mim_id":"607751","title":"TASTE RECEPTOR, TYPE 2, MEMBER 38; TAS2R38","url":"https://www.omim.org/entry/607751"},{"mim_id":"607715","title":"TSC22 DOMAIN FAMILY, MEMBER 1; TSC22D1","url":"https://www.omim.org/entry/607715"},{"mim_id":"263450","title":"POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5","url":"https://www.omim.org/entry/263450"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nuclear bodies","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TSC22D1"},"hgnc":{"alias_symbol":["TSC22","MGC17597"],"prev_symbol":["TGFB1I4"]},"alphafold":{"accession":"Q15714","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15714","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15714-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15714-F1-predicted_aligned_error_v6.png","plddt_mean":42.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TSC22D1","jax_strain_url":"https://www.jax.org/strain/search?query=TSC22D1"},"sequence":{"accession":"Q15714","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15714.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15714/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15714"}},"corpus_meta":[{"pmid":"20713358","id":"PMC_20713358","title":"Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20713358","citation_count":148,"is_preprint":false},{"pmid":"9458104","id":"PMC_9458104","title":"Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9458104","citation_count":78,"is_preprint":false},{"pmid":"12468551","id":"PMC_12468551","title":"Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12468551","citation_count":62,"is_preprint":false},{"pmid":"9459148","id":"PMC_9459148","title":"Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.","date":"1998","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9459148","citation_count":53,"is_preprint":false},{"pmid":"17147695","id":"PMC_17147695","title":"Specific TSC22 domain transcripts are hypertonically induced and alternatively spliced to protect mouse kidney cells during osmotic stress.","date":"2006","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/17147695","citation_count":52,"is_preprint":false},{"pmid":"9256356","id":"PMC_9256356","title":"The Drosophila bunched gene is a homologue of the growth factor stimulated mammalian TSC-22 sequence and is required during oogenesis.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9256356","citation_count":50,"is_preprint":false},{"pmid":"21791611","id":"PMC_21791611","title":"TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21791611","citation_count":49,"is_preprint":false},{"pmid":"15881652","id":"PMC_15881652","title":"Tsc-22 enhances TGF-beta signaling by associating with Smad4 and induces erythroid cell differentiation.","date":"2005","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15881652","citation_count":47,"is_preprint":false},{"pmid":"10879745","id":"PMC_10879745","title":"Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line.","date":"2000","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10879745","citation_count":45,"is_preprint":false},{"pmid":"11095965","id":"PMC_11095965","title":"Nuclear translocation of TSC-22 (TGF-beta-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11095965","citation_count":41,"is_preprint":false},{"pmid":"12501169","id":"PMC_12501169","title":"Downregulation of putative tumor suppressor gene TSC-22 in human brain tumors.","date":"2003","source":"Journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12501169","citation_count":39,"is_preprint":false},{"pmid":"21764761","id":"PMC_21764761","title":"Identification of fat4 and tsc22d1 as novel candidate genes for spontaneous pulmonary adenomas.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21764761","citation_count":34,"is_preprint":false},{"pmid":"19329776","id":"PMC_19329776","title":"TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19329776","citation_count":34,"is_preprint":false},{"pmid":"17174532","id":"PMC_17174532","title":"Altered expression of FHL1, CARP, TSC-22 and P311 provide insights into complex transcriptional regulation in pacing-induced atrial fibrillation.","date":"2006","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17174532","citation_count":31,"is_preprint":false},{"pmid":"10473130","id":"PMC_10473130","title":"Dynamic expression of TSC-22 at sites of epithelial-mesenchymal interactions during mouse development.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10473130","citation_count":31,"is_preprint":false},{"pmid":"18355271","id":"PMC_18355271","title":"A TSC22-like motif defines a novel antiapoptotic protein family.","date":"2008","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/18355271","citation_count":30,"is_preprint":false},{"pmid":"10906776","id":"PMC_10906776","title":"Expression of TGF-beta stimulated clone-22 (TSC-22) in mouse development and TGF-beta signalling.","date":"2000","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10906776","citation_count":28,"is_preprint":false},{"pmid":"22870275","id":"PMC_22870275","title":"Crucial role of TSC-22 in preventing the proteasomal degradation of p53 in cervical cancer.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22870275","citation_count":27,"is_preprint":false},{"pmid":"21448135","id":"PMC_21448135","title":"Antagonistic TSC22D1 variants control BRAF(E600)-induced senescence.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21448135","citation_count":26,"is_preprint":false},{"pmid":"18299979","id":"PMC_18299979","title":"TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.","date":"2008","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/18299979","citation_count":25,"is_preprint":false},{"pmid":"17622752","id":"PMC_17622752","title":"TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.","date":"2007","source":"Nephron. Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17622752","citation_count":24,"is_preprint":false},{"pmid":"18325344","id":"PMC_18325344","title":"Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18325344","citation_count":24,"is_preprint":false},{"pmid":"15379637","id":"PMC_15379637","title":"TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancer.","date":"2004","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/15379637","citation_count":23,"is_preprint":false},{"pmid":"18375761","id":"PMC_18375761","title":"The Drosophila homolog of human tumor suppressor TSC-22 promotes cellular growth, proliferation, and survival.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18375761","citation_count":23,"is_preprint":false},{"pmid":"18226226","id":"PMC_18226226","title":"Bunched, the Drosophila homolog of the mammalian tumor suppressor TSC-22, promotes cellular growth.","date":"2008","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18226226","citation_count":23,"is_preprint":false},{"pmid":"11944908","id":"PMC_11944908","title":"Cytoplasmic TSC-22 (transforming growth factor-beta-stimulated clone-22) markedly enhances the radiation sensitivity of salivary gland cancer cells.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11944908","citation_count":22,"is_preprint":false},{"pmid":"15610143","id":"PMC_15610143","title":"Role of TSC-22 during early embryogenesis in Xenopus laevis.","date":"2004","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/15610143","citation_count":21,"is_preprint":false},{"pmid":"17690703","id":"PMC_17690703","title":"Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD.","date":"2007","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/17690703","citation_count":21,"is_preprint":false},{"pmid":"11803572","id":"PMC_11803572","title":"Opposing effects on TSC-22 expression by BMP and receptor tyrosine kinase signals in the developing feather tract.","date":"2002","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/11803572","citation_count":21,"is_preprint":false},{"pmid":"12767908","id":"PMC_12767908","title":"Posttranscriptional regulation of TSC-22 (TGF-beta-stimulated clone-22) gene by TGF-beta 1.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12767908","citation_count":21,"is_preprint":false},{"pmid":"8982256","id":"PMC_8982256","title":"hDIP--a potential transcriptional regulator related to murine TSC-22 and Drosophila shortsighted (shs)--is expressed in a large number of human tissues.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8982256","citation_count":19,"is_preprint":false},{"pmid":"35513372","id":"PMC_35513372","title":"RNA-binding protein MEX3D promotes cervical carcinoma tumorigenesis by destabilizing TSC22D1 mRNA.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35513372","citation_count":17,"is_preprint":false},{"pmid":"17533171","id":"PMC_17533171","title":"The putative tumor suppressor Tsc-22 is downregulated early in chemically induced hepatocarcinogenesis and may be a suppressor of Gadd45b.","date":"2007","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/17533171","citation_count":16,"is_preprint":false},{"pmid":"30912127","id":"PMC_30912127","title":"The interplay between TGF-β-stimulated TSC22 domain family proteins regulates cell-cycle dynamics in medulloblastoma cells.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30912127","citation_count":15,"is_preprint":false},{"pmid":"20802130","id":"PMC_20802130","title":"Transforming growth factor-beta1 regulation of C-type natriuretic peptide expression in human vascular smooth muscle cells: dependence on TSC22D1.","date":"2010","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20802130","citation_count":15,"is_preprint":false},{"pmid":"19745830","id":"PMC_19745830","title":"TSC-22D1 isoforms have opposing roles in mammary epithelial cell survival.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19745830","citation_count":14,"is_preprint":false},{"pmid":"29228668","id":"PMC_29228668","title":"TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29228668","citation_count":11,"is_preprint":false},{"pmid":"18181769","id":"PMC_18181769","title":"Characterization of Ninjurin and TSC22 induction after X-irradiation of normal human skin cells.","date":"2008","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18181769","citation_count":10,"is_preprint":false},{"pmid":"16404353","id":"PMC_16404353","title":"Patterns of expression of TSC-22 protein in astrocytic gliomas.","date":"2005","source":"Experimental oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16404353","citation_count":10,"is_preprint":false},{"pmid":"11836610","id":"PMC_11836610","title":"Leucine zipper structure of TSC-22 (TGF-beta stimulated clone-22) markedly inhibits the anchorage-independent growth of salivary gland cancer cells.","date":"2002","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/11836610","citation_count":9,"is_preprint":false},{"pmid":"34681573","id":"PMC_34681573","title":"Identification of Binding Proteins for TSC22D1 Family Proteins Using Mass Spectrometry.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34681573","citation_count":8,"is_preprint":false},{"pmid":"18288391","id":"PMC_18288391","title":"Expression and cellular localization of TSC-22 in normal salivary glands and salivary gland tumors: implications for tumor cell differentiation.","date":"2008","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18288391","citation_count":8,"is_preprint":false},{"pmid":"26872059","id":"PMC_26872059","title":"Overexpression of TSC-22 (transforming growth factor- β-stimulated clone-22) causes marked obesity, splenic abnormality and B cell lymphoma in transgenic mice.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26872059","citation_count":8,"is_preprint":false},{"pmid":"12757981","id":"PMC_12757981","title":"The role of the TSC-22 (-396) A/G variant in the development of diabetic nephropathy.","date":"2003","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/12757981","citation_count":7,"is_preprint":false},{"pmid":"21881999","id":"PMC_21881999","title":"Regulation of TGF-β signaling by PKC depends on Tsc-22 inducibility.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21881999","citation_count":6,"is_preprint":false},{"pmid":"29481799","id":"PMC_29481799","title":"Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29481799","citation_count":5,"is_preprint":false},{"pmid":"26752201","id":"PMC_26752201","title":"TSC-22 Promotes Interleukin-2-Deprivation Induced Apoptosis in T-Lymphocytes.","date":"2016","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26752201","citation_count":5,"is_preprint":false},{"pmid":"11688842","id":"PMC_11688842","title":"Human TSC-22 gene: no association with type 2 diabetes.","date":"2001","source":"Internal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/11688842","citation_count":3,"is_preprint":false},{"pmid":"40901684","id":"PMC_40901684","title":"TSC22D1 promotes liver sinusoidal endothelial cell dysfunction and induces macrophage M1 polarization in non-alcoholic fatty liver disease.","date":"2025","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/40901684","citation_count":2,"is_preprint":false},{"pmid":"40679946","id":"PMC_40679946","title":"TSC22D1 is a newly identified inhibitor of insulin secretion in pancreatic beta cells.","date":"2025","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/40679946","citation_count":2,"is_preprint":false},{"pmid":"31227214","id":"PMC_31227214","title":"Generation of non-standard macrocyclic peptides specifically binding TSC-22 homologous gene-1.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31227214","citation_count":2,"is_preprint":false},{"pmid":"21873781","id":"PMC_21873781","title":"[Progress of TSC-22 gene research].","date":"2011","source":"Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21873781","citation_count":2,"is_preprint":false},{"pmid":"34447836","id":"PMC_34447836","title":"FGFR2-TSC22D1, a novel FGFR2 fusion gene identified in a patient with colorectal cancer: A case report.","date":"2021","source":"World journal of clinical cases","url":"https://pubmed.ncbi.nlm.nih.gov/34447836","citation_count":1,"is_preprint":false},{"pmid":"36285148","id":"PMC_36285148","title":"Transforming Stimulated Clone 22 (TSC-22) Interacts Directly with Bromodomain-Containing Protein 7 (BRD7) to Enhance the Inhibition of Extracellular Signal-Regulate Kinase (ERK) Pathway in Ovarian Cancer.","date":"2022","source":"Development & reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/36285148","citation_count":1,"is_preprint":false},{"pmid":"40544157","id":"PMC_40544157","title":"TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity.","date":"2025","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40544157","citation_count":0,"is_preprint":false},{"pmid":"41472023","id":"PMC_41472023","title":"Epstein-Barr Virus Promotes Gastric Cancer Progression by Modulating m6A-Dependent YTHDF1-TSC22D1 Axis.","date":"2025","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/41472023","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.12.628222","title":"NRBP1 and TSC22D proteins impact distal convoluted tubule physiology through modulation of the WNK pathway","date":"2024-12-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.12.628222","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.12.628181","title":"NRBP1 pseudokinase binds to and activates the WNK pathway in response to osmotic stress","date":"2024-12-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.12.628181","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.17.643825","title":"Regulation of Alternative Polyadenylation Events by PABPC1 Affects Erythroid Progenitor Cell Expansion","date":"2025-03-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.17.643825","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.06.26.600905","title":"Predictive and Experimental Motif Interaction Analysis Identifies Functions of the WNK-OSR1/SPAK Pathway","date":"2024-06-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.26.600905","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":30323,"output_tokens":8220,"usd":0.107134,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17839,"output_tokens":5303,"usd":0.110885,"stage2_stop_reason":"end_turn"},"total_usd":0.218019,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"TSC-22 (TSC22D1) was originally isolated as an immediate-early TGF-β1-inducible gene in mouse osteoblastic cells, encoding an ~18 kDa protein containing a leucine zipper motif and a TSC-box.\",\n      \"method\": \"Differential screening of osteoblast cDNA library; protein characterization\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — referenced across multiple independent papers as foundational finding, but original methods described only in secondary citations within corpus\",\n      \"pmids\": [\"15881652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Down-regulation of TSC-22 in human salivary gland cancer cells markedly enhanced their in vitro and in vivo growth, while up-regulation did not affect growth, establishing TSC-22 as a negative growth regulator relevant to salivary gland tumorigenesis.\",\n      \"method\": \"Sense/antisense cDNA transfection, ELISA protein quantification, in vitro growth assay, nude mouse tumorigenicity assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined cellular and in vivo phenotype, replicated in follow-up studies from same group\",\n      \"pmids\": [\"9458104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TSC-22 induction by vesnarinone required ongoing protein synthesis (blocked by cycloheximide), and antisense suppression of TSC-22 stimulated TYS cell growth and blocked vesnarinone's antiproliferative effect, confirming TSC-22 as a negative growth regulator.\",\n      \"method\": \"Antisense oligonucleotide treatment, cycloheximide block, cell growth assay\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — antisense loss-of-function with growth phenotype, consistent with independent study\",\n      \"pmids\": [\"9459148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TSC-22-GFP fusion protein localizes to the cytoplasm in living cells, but translocates to the nucleus in apoptotic cells; overexpression of cytoplasmic TSC-22 enhanced sensitivity to anticancer drugs (5-FU, CDDP, peplomycin) and markedly enhanced 5-FU-induced apoptosis.\",\n      \"method\": \"GFP fusion protein live-cell imaging, drug sensitivity assays, apoptosis assays in transfected cells\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization by live imaging tied to functional apoptosis outcome, single lab\",\n      \"pmids\": [\"10879745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TSC-22-GFP translocates from cytoplasm to nucleus specifically during apoptosis; TSC-22 fused to GAL4-DNA binding domain showed transcriptional activation in CHO cells but not HeLa or yeast, and the leucine zipper domain had greater transcriptional activity than full-length TSC-22.\",\n      \"method\": \"GFP fusion protein live/apoptotic cell imaging, GAL4-reporter assays in multiple cell lines and yeast\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional transcription reporter, multiple cell systems, single lab\",\n      \"pmids\": [\"11095965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Cytoplasmic localization of TSC-22 (full-length, containing nuclear export signal) enhanced radiation sensitivity of salivary gland cancer cells, whereas the nuclear-only TSC-22 (NLS-TSC-22LZ) had marginal effect; cytoplasmic TSC-22 translocated to nucleus during radiation-induced apoptosis, demonstrating that cytoplasmic-to-nuclear translocation is important for the cell death signal.\",\n      \"method\": \"Transfection of TSC-22 constructs with/without NLS/NES, radiation sensitivity assays, subcellular localization imaging\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-deletion constructs with localization and functional phenotype, single lab\",\n      \"pmids\": [\"11944908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The leucine zipper domain of TSC-22 is the active domain for inhibiting anchorage-independent colony formation; full-length TSC-22 (cytoplasmic) had weaker effect, and nuclear leucine zipper construct was most potent.\",\n      \"method\": \"Transfection of domain-deletion constructs, anchorage-independent growth (soft agar) assay\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutagenesis with functional phenotype, single lab\",\n      \"pmids\": [\"11836610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TSC-22 is a downstream effector of both PPARγ and TGF-β signaling in intestinal epithelial cells; transfection of wild-type TSC-22 reduced growth and increased p21, and a dominant-negative TSC-22 (both repressor domains deleted) reversed p21 induction and growth inhibition by PPARγ or TGF-β activation.\",\n      \"method\": \"PPARγ ligand treatment, TGF-β treatment, wild-type and dominant-negative TSC-22 transfection, p21 immunoblot, growth assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative epistasis places TSC-22 downstream of two pathways with defined phenotype, single lab\",\n      \"pmids\": [\"12468551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TGF-β1 upregulates TSC-22 mRNA through mRNA stabilization rather than transcriptional activation: the TSC-22 promoter was not activated by TGF-β signaling, but the 3'-UTR (containing Shaw-Kamens AUUUA sequences) destabilized heterologous mRNA, and TGF-β1 relieved this destabilization; a 40 kDa protein bound the 3'-UTR and this complex was decreased by TGF-β1.\",\n      \"method\": \"Promoter-luciferase assay, RNA-protein binding assay, heterologous mRNA stability reporter assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (luciferase, RNA-binding, stability assay), single lab\",\n      \"pmids\": [\"12767908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tsc-22 binds directly to Smad3 and Smad4 and modulates their transcriptional activity, enhancing TGF-β-dependent signaling; Tsc-22 also induced erythroid cell differentiation.\",\n      \"method\": \"Co-immunoprecipitation, transcriptional reporter assays, differentiation assays\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP binding to Smads with functional reporter, replicated in part by later studies\",\n      \"pmids\": [\"15881652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TSC-22 is a transcriptional suppressor of Gadd45b in mouse liver cells: siRNA knockdown of Tsc-22 increased Gadd45b gene and protein expression over time, and oxazepam treatment also decreased Tsc-22 and increased Gadd45b, placing Tsc-22 upstream of Gadd45b in an antiapoptotic pathway.\",\n      \"method\": \"siRNA knockdown, RT-PCR, western blot, oxazepam chemical treatment\",\n      \"journal\": \"Toxicological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined downstream target, two orthogonal perturbations (siRNA and chemical), single lab\",\n      \"pmids\": [\"17533171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TSC-22 interacts with fortilin (a nuclear anti-apoptotic protein), and fortilin overexpression reverses TSC-22-mediated apoptosis by promoting TSC-22 protein degradation; fortilin siRNA knockdown increased apoptosis.\",\n      \"method\": \"Yeast two-hybrid screening, Co-IP, overexpression/siRNA in ovarian carcinoma cells, apoptosis assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid + Co-IP binding, functional rescue experiment, single lab\",\n      \"pmids\": [\"18325344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Drosophila TSC-22 homolog Bunched (Bun) large isoforms promote cellular growth and proliferation; loss of large isoforms increases apoptosis and reduces cell size and division frequency in S2 cells and follicle cells, demonstrating a growth-promoting (not suppressive) function for the long isoform.\",\n      \"method\": \"Drosophila genetics (loss-of-function clonal analysis), S2 cell RNAi depletion, cell size and division measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotypes in multiple contexts, single lab\",\n      \"pmids\": [\"18375761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Drosophila bunched large isoform BunA promotes growth (cell number and cell size), while short isoforms BunB and BunC antagonize BunA function, establishing opposing roles for long vs. short isoforms at the single TSC-22/bun locus.\",\n      \"method\": \"Unbiased genetic screen, bun loss-of-function mutants, isoform-specific overexpression, cell size and number quantification\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic screen and isoform-specific rescue experiments, independent lab from PMID:18375761 but consistent results\",\n      \"pmids\": [\"18226226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A 16-residue sequence within the conserved 56-residue TSC22 domain (not the leucine zipper) is necessary for TSC-22's anti-apoptotic activity in yeast Bax-suppression assays; deletion mutagenesis and two-hybrid screening showed the antiapoptotic effect is independent of leucine zipper-mediated transcription.\",\n      \"method\": \"Yeast Bax-suppression assay, deletion mutagenesis, genome-wide two-hybrid screen, yeast overexpression/knockout\",\n      \"journal\": \"FEMS yeast research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional readout and deletion mapping, single lab\",\n      \"pmids\": [\"18355271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TSC-22D1 isoform 2 (short isoform) induces cell death in mammary epithelial cells and is upregulated during mammary gland involution, while isoform 1 (long isoform) suppresses TGF-β-induced cell death and enhances proliferation; the two isoforms exert opposing effects on cell survival.\",\n      \"method\": \"Isoform-specific overexpression/depletion in mammary epithelial cell lines, mammary gland in vivo expression analysis, cell death assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific gain/loss-of-function with defined cell survival phenotypes, single lab\",\n      \"pmids\": [\"19745830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TSC-22 promoter is hypermethylated in T/NK LGL leukemia, silencing its expression; targeted disruption of TSC-22 in mice enhanced proliferation and in vivo repopulation of hematopoietic precursor cells (HPCs), demonstrating a role for TSC-22 in restraining HPC expansion.\",\n      \"method\": \"Methylation analysis, 5-aza-2'-deoxycytidine treatment in vivo, TSC-22 knockout mouse model, HPC repopulation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse with defined HPC phenotype plus epigenetic mechanism, replicated across multiple disease models\",\n      \"pmids\": [\"19329776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TGF-β increases Tsc-22 protein levels post-transcriptionally in mesangial cells via miR-216a-mediated down-regulation of Ybx1; Ybx1 forms a ribonucleoprotein complex with Tsc-22 mRNA that stabilizes it, and TGF-β disrupts this complex to increase Tsc-22 protein. Tsc-22 then interacts with Tfe3 and both occupy E-box enhancers of Col1a2 to drive collagen expression.\",\n      \"method\": \"miRNA mimic/inhibitor oligonucleotides, Ybx1 shRNA knockdown, RNP complex co-immunoprecipitation, ChIP assay for Tsc-22 and Tfe3 on Col1a2 E-boxes, co-IP for Tsc-22/Tfe3 interaction\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (RNP-IP, ChIP, co-IP, miRNA perturbation) in single study establishing post-transcriptional regulation and chromatin occupancy\",\n      \"pmids\": [\"20713358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TSC22D1 is required for TGF-β1- and PDGF-BB-stimulated CNP (C-type natriuretic peptide) expression in human vascular smooth muscle cells; siRNA suppression of TSC22D1 (~90% knockdown) reduced TGF-β- and PDGF-stimulated CNP expression by 45–65%, establishing TSC22D1 as an enhancer of CNP transcription downstream of TGF-β.\",\n      \"method\": \"siRNA knockdown of TSC22D1, qRT-PCR for CNP and TSC22D1 mRNA, TGF-β1/PDGF-BB treatment in primary human vascular SMCs\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA loss-of-function with defined transcriptional target, two growth factor stimuli, single lab\",\n      \"pmids\": [\"20802130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TSC-22 facilitates TGF-β signaling by interacting with TβRI and Smad7 in mutually exclusive ways, disrupting the Smad7/Smurf-TβRI association and thereby preventing TβRI ubiquitination and degradation. This leads to enhanced Smad2/3 phosphorylation and promotes cardiac myofibroblast differentiation. The stimulatory effect of TSC-22 is abolished when Smad7 is silenced.\",\n      \"method\": \"Co-IP of TSC-22 with TβRI and Smad7, ubiquitination assays, Smad2/3 phosphorylation immunoblot, Smad7 siRNA epistasis, myofibroblast differentiation markers (α-SMA, PAI-1, fibronectin, collagen I), isoproterenol rat model\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ubiquitination assay, siRNA epistasis, and in vivo corroboration; multiple orthogonal methods in one study\",\n      \"pmids\": [\"21791611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BRAF(E600)-induced senescence upregulates only the short TSC22D1 transcript (>100-fold); the long TSC22D1 protein variant is degraded by proteasomal degradation. Short and long TSC22D1 variants form complexes with their dimerization partner THG1 and exert opposing functions: depletion of the short form or overexpression of the long form abrogates oncogene-induced senescence (OIS). TSC22D1 acts as a critical effector of C/EBPβ in OIS, controlling inflammatory factors and p15(INK4B).\",\n      \"method\": \"Gene expression profiling, isoform-specific depletion (short form), long isoform overexpression, proteasome inhibition, senescence assays, C/EBPβ epistasis analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific gain/loss-of-function with mechanistic pathway placement (C/EBPβ), multiple orthogonal methods, defined OIS phenotype\",\n      \"pmids\": [\"21448135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKC regulation of TGF-β signaling depends on Tsc-22 inducibility: in cells where Tsc-22 is induced, Tsc-22 enhances TGF-β-dependent signaling, and a dominant-negative Tsc-22 mutant blocks this enhancement, demonstrating cell-type-specific modulation of the Smad-PKC axis by Tsc-22.\",\n      \"method\": \"Dominant-negative TSC-22 mutant transfection, TGF-β signaling reporter assays, comparison across cell types\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — dominant-negative experiment in single lab without detailed mechanistic dissection\",\n      \"pmids\": [\"21881999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TSC-22 binds directly to p53 at the motif between amino acids 100–200, inhibiting HDM2- and E6-mediated poly-ubiquitination and degradation of p53, thereby stabilizing p53 and activating p21(Waf1/Cip1) and PUMA expression. TSC-22 siRNA knockdown enhanced p53 poly-ubiquitination. Notably, TSC-22 did not affect the p53–HDM2 interaction itself.\",\n      \"method\": \"Co-IP of TSC-22 and p53, ubiquitination assays, siRNA knockdown, overexpression in cervical cancer cells and xenograft model, p21/PUMA western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination assay, and siRNA with defined downstream targets, single lab\",\n      \"pmids\": [\"22870275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TSC-22 promotes apoptosis in IL-2-deprived T-lymphocytes by inhibiting GILZ expression at the transcriptional level, resulting in increased BIM expression and elevated caspase-9 and caspase-3 activities.\",\n      \"method\": \"TSC-22 overexpression in CTLL-2 and NKL cell lines, IL-2 withdrawal apoptosis assay, GILZ mRNA quantification, BIM/caspase activity measurements\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with defined transcriptional target and apoptosis pathway, single lab\",\n      \"pmids\": [\"26752201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TSC-22 interacts with the intracellular tyrosine kinase insert domain (aa 539–749) of CSF-1R, blocking AKT and ERK signaling and suppressing NF-κB transcriptional activity; TSC-22 overexpression also decreased CSF-1R protein levels, disrupting its autocrine signaling loop.\",\n      \"method\": \"Co-IP of TSC-22 and CSF-1R, domain mapping, AKT/ERK/NF-κB signaling assays, CSF-1R protein level quantification, xenograft tumor model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping plus downstream signaling readouts, single lab\",\n      \"pmids\": [\"29228668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TSC22D4-TSC22D1 short isoform heterodimers promote cell cycle exit and escape from proliferation in medulloblastoma cells, whereas the TSC22D1 long isoform supports cell proliferation independently of TSC22D4; silencing specific isoforms affects cell-cycle progression.\",\n      \"method\": \"siRNA isoform-specific knockdown of TSC22D1 long/short and TSC22D4, cell cycle analysis in DAOY medulloblastoma cells\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific RNAi with cell cycle phenotype, single lab\",\n      \"pmids\": [\"30912127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TSC22D1-1 (long isoform) localizes predominantly to the nucleus; TSC-22 (TSC22D1-2, short isoform) localizes to the cytoplasm (mainly mitochondria) and translocates to nucleus after DNA damage; TSC22(86) (TSC22D1-3) localizes to both compartments. Pull-down and in vivo binding assays identified Histone H1 as a binding partner of TSC22D1-2 and TSC22D1-3 in the nucleus, and GNL3/nucleostemin as a binding partner of TSC22D1-2 in the nucleus.\",\n      \"method\": \"GFP-fusion localization imaging, subcellular fractionation, in vitro pull-down assays, in vivo binding assays, mass spectrometry\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments plus pull-down/MS identification of binding partners, single lab\",\n      \"pmids\": [\"34681573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MEX3D RNA-binding protein directly binds TSC22D1 mRNA and destabilizes it, reducing TSC22D1 expression in cervical cancer; MEX3D knockdown increased TSC22D1 levels, and this was confirmed by RNA pull-down, RNA immunoprecipitation, and mRNA stability assays.\",\n      \"method\": \"RNA pull-down, RNA immunoprecipitation (RIP), mRNA stability assays, MEX3D knockdown, western blot\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal RNA-binding assays establishing direct RBP-mRNA interaction with functional mRNA stability consequence, single lab\",\n      \"pmids\": [\"35513372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TSC-22 directly interacts with BRD7 and potentiates BRD7-mediated inactivation of the ERK signaling pathway in ovarian cancer cells.\",\n      \"method\": \"Co-IP identification of TSC-22/BRD7 interaction, ERK pathway activity assays with TSC-22 overexpression\",\n      \"journal\": \"Development & Reproduction\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP with downstream signaling readout, single lab, limited detail in abstract\",\n      \"pmids\": [\"36285148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TSC22D1 long isoform (TSC22D1.1) localizes to WNK bodies (cytoplasmic biomolecular condensates) in the distal convoluted tubule of the kidney and positively modulates WNK4 signaling; long TSC22D isoforms and NRBP1 increase WNK4 activity in HEK293 cells, and this is associated with regulation of NCC phosphorylation and Na+ reabsorption.\",\n      \"method\": \"Subcellular localization in kidney DCT cells, HEK293 WNK4 activity assay, DCT-specific NRBP1 knockout mouse model, NCC phosphorylation immunoblot\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — localization in native tissue context, in vitro kinase pathway assay, and KO mouse with defined physiological phenotype; preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.12.12.628222\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TSC22D1 contains an RΦ-motif that interacts with the CCT-like domain of the pseudokinase NRBP1, and AlphaFold-3 modeling predicts TSC22D1 forms part of a multi-subunit complex with WNK1, SPAK, and TSC22D4 via RΦ-motif interactions with CCT domains.\",\n      \"method\": \"Motif interaction analysis, immunoprecipitation, mass spectrometry, AlphaFold-3 structural modeling\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — structural model is computational; experimental validation of TSC22D1 motif binding to NRBP1 CCT domain shown by peptide binding but full complex not reconstituted; preprint\",\n      \"pmids\": [\"bio_10.1101_2024.06.26.600905\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TSC22D1 interacts with FoxO1 in a reciprocal manner to regulate pancreatic beta cell function; TSC22D1 depletion in INS-1E cells enhanced expression of beta cell identity genes (Ins1, Ins2, Pdx1, Slc2a2, Nkx6.1) and promoted glucose-stimulated insulin secretion without altering intracellular insulin content.\",\n      \"method\": \"TSC22D1 siRNA depletion in INS-1E cells, glucose-stimulated insulin secretion assay, gene expression profiling (RNA-Seq), interactome analysis, Co-IP of TSC22D1 and FoxO1\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined transcriptional and secretory phenotype plus Co-IP interaction, single lab\",\n      \"pmids\": [\"40679946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TSC22D1 drives liver sinusoidal endothelial cell (LSEC) dysfunction and M1 macrophage polarization via the TWEAK/FN14 signaling pathway; TSC22D1 overexpression in LSECs increased pro-inflammatory cytokine secretion and LSEC microvascularization/EndMT, and TWEAK inhibition attenuated these effects; AAV8-shRNA inhibition of TSC22D1 in vivo reduced NAFLD progression.\",\n      \"method\": \"Single-cell transcriptomic analysis, TSC22D1 overexpression in human LSECs, flow cytometry, ELISA, TWEAK inhibitor treatment, AAV8-shRNA in vivo knockdown in NAFLD mice\",\n      \"journal\": \"World journal of gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo loss/gain-of-function with defined pathway (TWEAK/FN14) and cellular phenotypes, single lab\",\n      \"pmids\": [\"40901684\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TSC22D1 encodes a leucine zipper/TSC-box protein whose two major isoforms (long and short) exert opposing functions: the short isoform (TSC-22/TSC22D1-2) localizes to the cytoplasm (primarily mitochondria), translocates to the nucleus upon apoptotic or DNA damage stimuli, promotes cell cycle exit, p53 stabilization (by blocking poly-ubiquitination), and apoptosis, while suppressing oncogene-induced senescence when absent; the long isoform (TSC22D1-1) promotes cell proliferation and growth and is required for full TGF-β signaling amplification by displacing the Smad7/Smurf inhibitory complex from TβRI to prevent receptor degradation. Both isoforms act downstream of TGF-β (with mRNA upregulation achieved post-transcriptionally via mRNA stabilization rather than transcriptional activation), interact with Smad3/4, Tfe3, p53, fortilin, CSF-1R, FoxO1, WNK kinases (via RΦ-motif/CCT interactions), and BRD7, and their relative balance controls cell proliferation, differentiation, senescence, and organ-specific physiology including renal Na⁺ reabsorption and pancreatic beta cell function.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TSC22D1 encodes a leucine-zipper/TSC-box protein originally isolated as an immediate-early TGF-\\u03b21-inducible gene [#0] that functions as a context-dependent regulator of cell proliferation, survival, and differentiation downstream of TGF-\\u03b2 signaling. Its expression is controlled largely post-transcriptionally: TGF-\\u03b21 stabilizes TSC22D1 mRNA by relieving 3'-UTR-mediated destabilization [#8], and TGF-\\u03b2 acting through miR-216a-dependent loss of the stabilizing protein Ybx1 raises Tsc-22 protein levels [#17], while the RNA-binding protein MEX3D directly binds and destabilizes TSC22D1 mRNA [#27]. The locus produces functionally opposing isoforms: a short cytoplasmic isoform that translocates to the nucleus upon apoptotic or DNA-damage stimuli to drive cell death, and a long isoform that supports proliferation and growth [#15, #20, #26], a division mirrored in the Drosophila bunched locus where long isoforms promote growth and short isoforms antagonize them [#13]. Mechanistically, TSC22D1 amplifies TGF-\\u03b2 signaling by binding Smad3/Smad4 [#9] and by competing with the Smad7/Smurf inhibitory complex at the type I receptor T\\u03b2RI to block its ubiquitination and degradation, thereby sustaining Smad2/3 phosphorylation and myofibroblast differentiation [#19]; it also partners with Tfe3 at Col1a2 E-box enhancers to drive collagen expression [#17]. Its short isoform promotes apoptosis and cell-cycle exit by stabilizing p53 through inhibition of HDM2/E6-mediated poly-ubiquitination, activating p21 and PUMA [#22], by repressing the anti-apoptotic targets Gadd45b [#10] and GILZ [#23], and acts as an effector of C/EBP\\u03b2 in oncogene-induced senescence [#20]. Loss-of-function studies establish it as a negative growth regulator in salivary gland cancer [#1, #2] and a restraint on hematopoietic precursor expansion [#16]. Additional roles include modulation of WNK4 kinase signaling and renal Na\\u207a handling via the long isoform localizing to WNK bodies [#29] and reciprocal regulation of FoxO1 in pancreatic beta-cell function [#31].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Established the molecular identity of TSC22D1 as a TGF-\\u03b2-responsive leucine-zipper/TSC-box protein, defining the structural elements later dissected for function.\",\n      \"evidence\": \"Differential cDNA screening of TGF-\\u03b21-induced osteoblasts and protein characterization\",\n      \"pmids\": [\"15881652\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Original isolation described only in secondary citations within the corpus\", \"No structural model of the TSC-box or leucine zipper\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated that TSC22D1 acts as a tumor-suppressive negative growth regulator, answering whether its TGF-\\u03b2 inducibility translated into a growth-restraining cellular role.\",\n      \"evidence\": \"Sense/antisense transfection, nude-mouse tumorigenicity, antisense oligonucleotide and cycloheximide block in salivary gland cancer cells\",\n      \"pmids\": [\"9458104\", \"9459148\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of growth suppression not resolved\", \"Isoform contributions not distinguished\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked TSC22D1 subcellular trafficking to apoptotic signaling and mapped the active domains, showing cytoplasmic-to-nuclear translocation drives the cell-death response and the leucine zipper mediates growth suppression.\",\n      \"evidence\": \"GFP-fusion live-cell imaging, NLS/NES constructs, GAL4-reporter and soft-agar assays in cancer cells\",\n      \"pmids\": [\"10879745\", \"11095965\", \"11944908\", \"11836610\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Translocation trigger and transport machinery unidentified\", \"Direct transcriptional targets of the leucine zipper not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved how TGF-\\u03b2 raises TSC22D1 levels, showing regulation is post-transcriptional via 3'-UTR mRNA stabilization rather than promoter activation.\",\n      \"evidence\": \"Promoter-luciferase, RNA-protein binding, and heterologous mRNA stability reporter assays\",\n      \"pmids\": [\"12767908\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the 40 kDa 3'-UTR-binding protein not established\", \"Did not connect stabilization to downstream phenotype\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed TSC22D1 upstream of specific apoptotic effectors as a transcriptional suppressor of Gadd45b, extending its role beyond TGF-\\u03b2 amplification.\",\n      \"evidence\": \"siRNA knockdown and oxazepam treatment with RT-PCR/western in mouse liver cells\",\n      \"pmids\": [\"17533171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect repression of Gadd45b not distinguished\", \"No promoter occupancy data\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the opposing-isoform paradigm and a leucine-zipper-independent anti-apoptotic activity, reframing TSC22D1 as a locus encoding antagonistic long and short products.\",\n      \"evidence\": \"Drosophila bunched genetics, isoform-specific overexpression, yeast Bax-suppression assay and deletion mapping; fortilin yeast two-hybrid and Co-IP\",\n      \"pmids\": [\"18375761\", \"18226226\", \"18355271\", \"18325344\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mammalian validation of fly isoform model incomplete at this stage\", \"Mechanism by which the TSC22-domain peptide suppresses apoptosis unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Confirmed in mammalian cells that the short isoform induces death while the long isoform suppresses TGF-\\u03b2-induced death, and linked TSC22D1 to restraint of hematopoietic precursor expansion via epigenetic silencing.\",\n      \"evidence\": \"Isoform-specific gain/loss in mammary epithelium and in vivo involution analysis; promoter methylation analysis and TSC-22 knockout mouse HPC repopulation assay\",\n      \"pmids\": [\"19745830\", \"19329776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of opposing isoform outputs not fully defined\", \"Tissue-specific isoform ratios uncharacterized\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified a complete post-transcriptional control circuit (miR-216a/Ybx1) and a chromatin-level effector function with Tfe3, linking TGF-\\u03b2 input to collagen gene output.\",\n      \"evidence\": \"miRNA mimic/inhibitor, Ybx1 shRNA, RNP-IP, co-IP and ChIP on Col1a2 E-boxes in mesangial cells; siRNA in vascular SMCs for CNP\",\n      \"pmids\": [\"20713358\", \"20802130\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Tfe3 partnership generalizes beyond Col1a2 unknown\", \"Isoform identity at chromatin not specified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established the core mechanism of TGF-\\u03b2 amplification\\u2014TSC22D1 displaces Smad7/Smurf from T\\u03b2RI to block receptor degradation\\u2014and defined its role as a C/EBP\\u03b2 effector in oncogene-induced senescence.\",\n      \"evidence\": \"Reciprocal Co-IP, ubiquitination assays, Smad7 siRNA epistasis and isoproterenol rat model; isoform-specific depletion/overexpression, proteasome inhibition and C/EBP\\u03b2 epistasis in OIS\",\n      \"pmids\": [\"21791611\", \"21448135\", \"21881999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of T\\u03b2RI/Smad7 competition not resolved\", \"How short-isoform induction is selectively triggered in senescence unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified a direct p53-stabilizing mechanism, explaining how the short isoform engages the apoptotic/cell-cycle-arrest program independently of transcription.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, siRNA and overexpression with xenograft in cervical cancer cells\",\n      \"pmids\": [\"22870275\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How TSC-22 blocks ubiquitination without affecting p53\\u2013HDM2 binding is unexplained\", \"Structural basis of the aa100\\u2013200 interaction unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extended the pro-apoptotic mechanism to immune cells, showing transcriptional repression of GILZ drives BIM-dependent caspase activation upon IL-2 deprivation.\",\n      \"evidence\": \"Overexpression in CTLL-2/NKL cells with IL-2 withdrawal, GILZ/BIM and caspase readouts\",\n      \"pmids\": [\"26752201\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect GILZ repression not established\", \"Isoform responsible not specified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Broadened the interactome to receptor tyrosine kinase signaling, showing TSC22D1 binds the CSF-1R kinase insert and suppresses AKT/ERK/NF-\\u03baB output.\",\n      \"evidence\": \"Co-IP, domain mapping, downstream signaling assays and xenograft\",\n      \"pmids\": [\"29228668\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether interaction directly inhibits kinase activity unknown\", \"Isoform specificity not determined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Resolved isoform-specific subcellular distributions and identified new nuclear binding partners, refining the spatial logic of TSC22D1 isoform function.\",\n      \"evidence\": \"GFP localization, subcellular fractionation, pull-down and MS in transfected cells\",\n      \"pmids\": [\"34681573\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequences of Histone H1 and GNL3 binding not tested\", \"Mitochondrial role of the short isoform undefined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Added MEX3D as a direct destabilizing regulator of TSC22D1 mRNA and BRD7 as a cooperating ERK-pathway partner, expanding upstream and signaling control.\",\n      \"evidence\": \"RNA pull-down, RIP and stability assays with MEX3D knockdown; Co-IP and ERK assays for BRD7\",\n      \"pmids\": [\"35513372\", \"36285148\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"BRD7 interaction supported by a single Co-IP with limited detail\", \"Interplay between MEX3D and TGF-\\u03b2-driven stabilization untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined organ-specific physiological roles, implicating TSC22D1 in renal WNK signaling, pancreatic beta-cell identity/insulin secretion via FoxO1, and NAFLD-associated endothelial dysfunction via TWEAK/FN14.\",\n      \"evidence\": \"WNK body localization and HEK293 WNK4 activity assays with NRBP1 KO mouse (preprint); siRNA depletion, RNA-Seq and Co-IP in INS-1E cells; single-cell transcriptomics, overexpression and AAV8-shRNA in NAFLD mice\",\n      \"pmids\": [\"bio_10.1101_2024.12.12.628222\", \"40679946\", \"40901684\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether WNK-pathway role connects to the canonical TGF-\\u03b2/apoptosis functions unknown\", \"FoxO1 and TWEAK/FN14 mechanisms not integrated with isoform biology\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TSC22D1 assembles into a higher-order complex with NRBP1/WNK/SPAK via R\\u03a6-motif/CCT interactions, and how this structural context governs the choice between its proliferative and pro-apoptotic outputs, remains unresolved.\",\n      \"evidence\": \"AlphaFold-3 modeling with peptide-binding validation; full complex not reconstituted (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Predicted multi-subunit complex computationally modeled but not experimentally reconstituted\", \"No structure of any TSC22D1 protein complex\", \"Determinants selecting long vs. short isoform function unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [10, 17, 20, 23]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [19, 22, 24]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [9, 19]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 4, 5, 26]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 4, 5, 26]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 22, 23]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [20, 25]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"complexes\": [\"WNK bodies\"],\n    \"partners\": [\"SMAD3\", \"SMAD4\", \"SMAD7\", \"TGFBR1\", \"TFE3\", \"TP53\", \"FOXO1\", \"NRBP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}